NCT04855578 |
Deprescription of Gabapentinoids in Medical Inpatients
(GABA-WHY) |
19th April 2021 |
Recruiting |
12th April 2022 |
Canada |
Non-RCT |
Inpatients ≥60
years who have a gabapentinoid prescription prior to admission. |
In-hospital patient educational
brochure
Physician education about gabapentinoid
prescriptions
|
Usual care |
Cessation or dose reduction, QoL, pain
intensity, initiation of new pain medication |
At study enrolment, 8
weeks post-discharge |
NCT00647322 |
The impact of reducing overtreatment on quality of life in
children with refractory epilepsy |
26th March 2008 |
Unknown |
31st March 2008 |
United Kingdom |
Non-RCT |
Patients 6 to 21 years with intractable epilepsy receiving antiepileptic
drug polytherapy |
Reduction of anti-epileptic medications |
Usual care |
Dose reduction, QoL |
At study enrolment and 6 months after entering
the study |
ACTRN12618000729224 |
Deprescribing anticholinergic and sedative
medications in older people - a randomised controlled trial |
2nd May 2018 |
Recruitment completed. Last follow-up
completed 03/06/2021 |
3rd December 2021 |
New Zealand |
RCT |
Patients ≥60 years, prescribed at least one anticholinergic or
sedative medication in the last year and currently undergoing or have
had an InterRAI assessment in the previous 12 months. |
Pharmacist-led
comprehensive medication review |
Usual care |
Dose reduction,
medication use, mortality |
6 months after randomisation, 3 and 6 months
after trial ends |